Why Is Tesla Stock Falling?
Tesla stock reached an all-time high of $479.86 on December…
Sell
21
CBUS Quote, Financials, Valuation and Earnings
Last price:
$2.54
Seasonality move
:
-26.67%
Day range:
$2.50 - $2.60
52-week range:
$2.17 - $23.18
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.69x
P/B ratio:
0.72x
Volume:
65.1K
Avg. volume:
143.9K
1-year change:
-86.02%
Market cap:
$77.9M
Revenue:
$1.8M
EPS (TTM):
-$55.53
Analysts' Opinion
-
Consensus RatingCibus has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $17.63, Cibus has an estimated upside of 596.64% from its current price of $2.53.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $4.00 representing 100% downside risk from its current price of $2.53.
Fair Value
-
According to the consensus of 3 analysts, Cibus has 596.64% upside to fair value with a price target of $17.63 per share.
CBUS vs. S&P 500
-
Over the past 5 trading days, Cibus has underperformed the S&P 500 by -0.66% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Cibus does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cibus has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Cibus reported revenues of $1.7M.
Earnings Growth
-
Cibus has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Cibus reported earnings per share of -$38.15.
Enterprise value:
62.5M
EV / Invested capital:
--
Price / LTM sales:
7.69x
EV / EBIT:
--
EV / Revenue:
15.04x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-1.00x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-80.32%
Net Income Margin (TTM):
-10811.34%
Return On Equity:
-133.74%
Return On Invested Capital:
-133.31%
Operating Margin:
-1140.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $2.1M | $756K | $4.2M | $475K | $1.7M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$25.8M | -$52.9M | -$78.8M | -$25.8M | -$19M | |
| EBITDA | -$19M | -$49.2M | -$493M | -$24.7M | -$190.9M | |
| Diluted EPS | -$24.72 | -$31.66 | -$55.53 | -$7.95 | -$38.15 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $38.3M | $17.3M | $7.9M | $34.5M | $31.6M | |
| Total Assets | $62.5M | $39.5M | $26.7M | $796.2M | $367.9M | |
| Current Liabilities | $7.9M | $5.1M | $4.2M | $25.1M | $21.9M | |
| Total Liabilities | $27.6M | $23.7M | $17.9M | $203.7M | $247M | |
| Total Equity | $34.9M | $15.8M | $8.8M | $592.5M | $120.9M | |
| Total Debt | $1.5M | -- | -- | $1.8M | $628K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$19.8M | -$33M | -$61.1M | -$15.1M | -$13.5M | |
| Cash From Investing | -$1.6M | $55.5M | -$1.2M | -$3.3M | -$355K | |
| Cash From Financing | $13.7M | $2.1M | $59.2M | -$619K | $12.7M | |
| Free Cash Flow | -$21.4M | -$36.8M | -$62.3M | -$18.4M | -$13.9M | |
CBUS
Sector
Market Cap
$77.9M
$43.4M
Price % of 52-Week High
10.92%
48.26%
Dividend Yield
0%
0%
Shareholder Yield
-74.14%
-0.75%
1-Year Price Total Return
-86.02%
-34.26%
Beta (5-Year)
1.826
0.749
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$2.53
200-day SMA
Sell
Level
$6.85
Bollinger Bands (100)
Sell
Level
2.62 - 4.3
Chaikin Money Flow
Sell
Level
-103.6M
20-day SMA
Buy
Level
$2.50
Relative Strength Index (RSI14)
Sell
Level
45.01
ADX Line
Buy
Level
10.92
Williams %R
Neutral
Level
-44.7368
50-day SMA
Sell
Level
$2.93
MACD (12, 26)
Sell
Level
-0.09
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Neutral
Level
48.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-1.9561)
Sell
CA Score
(Annual)
Level (-5.3934)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (4.9038)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Stock Forecast FAQ
In the current month, CBUS has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CBUS average analyst price target in the past 3 months is $17.63.
-
Where Will Cibus Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cibus share price will rise to $17.63 per share over the next 12 months.
-
What Do Analysts Say About Cibus?
Analysts are divided on their view about Cibus share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cibus is a Sell and believe this share price will drop from its current level to $4.00.
-
What Is Cibus's Price Target?
The price target for Cibus over the next 1-year time period is forecast to be $17.63 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CBUS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cibus is a Buy. 2 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CBUS?
You can purchase shares of Cibus via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cibus shares.
-
What Is The Cibus Share Price Today?
Cibus was last trading at $2.54 per share. This represents the most recent stock quote for Cibus. Yesterday, Cibus closed at $2.53 per share.
-
How To Buy Cibus Stock Online?
In order to purchase Cibus stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is DoorDash a Buy, Sell or Hold?
Gig economy food delivery service DoorDash (NASDAQ:DASH) has been running…
Is Clorox’s Dividend Worth It?
Clorox (NYSE:CLX) is the parent company of some of the…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 116x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $3T
P/E Ratio: 35x
Alerts
Buy
87
PCOR alert for Feb 15
Procore Technologies [PCOR] is up 16.3% over the past day.
Buy
54
DKNG alert for Feb 15
DraftKings [DKNG] is up 15.24% over the past day.
Sell
30
TWLO alert for Feb 15
Twilio [TWLO] is down 15.01% over the past day.
